about
sameAs
Trends in malaria cases, hospital admissions and deaths following scale-up of anti-malarial interventions, 2000-2010, RwandaAchieving high coverage in Rwanda's national human papillomavirus vaccination programmeAssessing Odor Level when Using PrePex for HIV Prevention: A Prospective, Randomized, Open Label, Blinded Assessor Trial to Improve Uptake of Male CircumcisionPrevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in RwandaCombatting substandard and falsified medicines: a view from RwandaArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialFailure to detect Plasmodium vivax in West and Central Africa by PCR species typingMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsImpact of implementing performance-based financing on childhood malnutrition in RwandaHigh risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiencyDiagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurementPaediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries2009 pandemic influenza A (H1N1) virus outbreak and response--Rwanda, October, 2009-May, 2010.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataComparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.Rwanda 20 years on: investing in lifeDeterminants of circumcision and willingness to be circumcised by Rwandan men, 2010Monitoring long-lasting insecticidal net (LLIN) durability to validate net serviceable life assumptions, in RwandaNationwide implementation of integrated community case management of childhood illness in RwandaPrevalence and risk factors of malaria among children in southern highland Rwanda.Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Under-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program.The Rwanda Field Epidemiology and Laboratory Training Program: training skilled disease detectivesHIV-free survival among nine- to 24-month-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey.Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.Validating the Children's Depression Inventory in the context of RwandaPharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria.Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.Operational challenges to continuous LLIN distribution: a qualitative rapid assessment in four countriesArtemisinin resistance in rodent malaria--mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking.Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural RwandaFactors associated with the non-use of insecticide-treated nets in Rwandan children.Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment.Shared learning in an interconnected world: innovations to advance global health equityApplied statistical training to strengthen analysis and health research capacity in Rwanda.Malaria has no effect on birth weight in Rwanda.
P50
Q21034110-3F49B387-225A-451E-9BB8-011F8EFE3F99Q21034174-D54333C1-7A0E-4486-A20E-D56336F83684Q21034183-C3748676-900D-4393-989C-214B78D712DEQ21034187-C388A01D-3AF9-4317-90EC-376189AAA9F8Q21034188-E27FA22D-DD6B-4A33-B364-E149E9C26439Q24630683-41250F06-26A1-4016-9329-38A1602CEB1CQ24646965-13AAFC0B-6044-421C-9369-FED6B167BFB9Q27000750-05DB402D-EF5C-41D2-AE44-A3BE1B40BDF5Q27497156-9B0EA4D5-9E7C-41BA-88D1-49E693D5AADDQ28474365-527EBDE5-3497-43A0-878B-577C0716E00BQ28482447-8A5A29E2-4E5A-4D58-828E-1CCE91170DB2Q28538338-B13337C3-4F20-489B-8773-F38AB12314A8Q30418664-2F2970D2-C731-4037-8FF7-3F93A60D2507Q30936416-A3A82A98-CA42-4925-A0C6-26F2AAF6176AQ33399342-64D3A5E8-73A9-4210-A624-4074D588F14AQ33489551-B78545CF-E8C8-4D7D-B035-158B77098938Q33559071-6DF4085F-EFD4-48D2-AC53-96F5C73D8932Q34121092-3C2AA805-C707-4A06-89EF-704D230D145BQ34160503-E17582E5-F4AA-4EE5-8E00-E3A0BC333CC4Q34168715-84D3BD89-2D4B-4953-881C-6219AA844572Q34210877-1C0CA61D-DFEE-4BB8-B106-5FEFE3F6BDD7Q35063833-5AD8D483-92D4-47F3-9029-C0A40205A5B8Q35245962-6A2741E3-F198-43F5-BE10-29204BDCBE4DQ35548335-86546152-AE68-45A8-AA47-F366765A1CADQ35698364-FCB37C02-548D-4D0D-A8FB-142313C85F7EQ35800191-92454933-4B3E-4767-8A60-3BFEE4885F86Q35845345-F405D80F-6980-4BB7-9047-96C551E6E806Q35929609-CC8A57C7-7D39-4A7B-AF75-F89FCC1B9AF7Q36125279-1420DB94-11D2-484E-8706-9B66A6E3B5B3Q36309115-080B6F1A-E3E5-4F34-90B8-E5623DAC26A7Q36346372-EE705A86-BD9C-4AF9-AE5C-E90CC708B254Q36413462-E49EBE4A-8F47-413E-9C28-04157CA25146Q36639413-2867E4B2-3B29-4D7D-8FBB-C45352842AF6Q36849304-7FF9938B-3A6B-41EB-AFCD-10601C3215FDQ36917007-95DC2647-C203-48FE-BCF7-C21D8BB17C32Q37090179-0CB10533-25D3-487D-B725-6B7A9361DAACQ37122733-B075796D-4812-4A03-B9FF-DD2D1B548B57Q37153091-461B8580-CFAC-4534-A63D-A9F3355FD9D8Q37294928-93CBC193-52D5-4C42-B0FC-FD182F4115D6Q37309935-9C461D24-EAA5-4BA3-9761-933D38FF3F9B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Corine Karema
@ast
Corine Karema
@en
Corine Karema
@es
Corine Karema
@nl
Corine Karema
@sl
type
label
Corine Karema
@ast
Corine Karema
@en
Corine Karema
@es
Corine Karema
@nl
Corine Karema
@sl
prefLabel
Corine Karema
@ast
Corine Karema
@en
Corine Karema
@es
Corine Karema
@nl
Corine Karema
@sl
P106
P21
P31
P496
0000-0002-6099-7768